Direct economic burden of hepatitis B virus related diseases: Evidence from Shandong, China

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Lu, Jingjing ^a,b   Xu, Aiqiang ^a   Wang, Jian ^b   Zhang, Li ^a   Song, Lizhi ^a   Li, Renpeng ^a   Zhang, Shunxiang ^c   Zhuang, Guihua ^d   Lu, Mingshan ^e  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINA; COMPARATIVE STUDY; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HOSPITALIZATION; HUMAN; HUMAN RELATION; INTERVIEW; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; NONPARAMETRIC TEST; SOCIOECONOMICS; STATISTICS; TREATMENT OUTCOME; VIROLOGY;

ADULT; CHINA; COST OF ILLNESS; DIRECT SERVICE COSTS; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS B VIRUS; HOSPITALIZATION; HUMANS; INTERVIEWS AS TOPIC; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROFESSIONAL-PATIENT RELATIONS; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

MLCS; MLOWN;

EID: 84873025782     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-37     Document Type: Article

References (10)

1. Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y, Vaccine 2009 27 1 6550 6557 19729084
2. Cost of chronic Hepatitis B infection in China. Zhiqiang G, Zhaohui D, Qinhuan W, Dexian C, Yunyun F, Hongtao L, Iloeje UH, J Clin Gastroenterol 2004 38 10 Suppl 3 175 S178 15602167
3. Assessment of total economic burden of chronic Hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China. Hu M, Chen W, Value Health 2009 12 Suppl 3 89 S92 20586991
4. Cost of chronic Hepatitis B infection in South Korea. Yang BM, Kim CH, Kim JY, J Clin Gastroenterol 2004 38 10 Suppl 3 153 S157 15602164
5. The economic burden of Hepatitis B in Germany. Harbarth S, Szucs T, Berger K, Jilg W, Eur J Epidemiol 2000 16 2 173 177 10.1023/A:1007624415699 10845268 (Pubitemid 30322124)
6. A cost comparison of management of chronic Hepatitis B and its associated complications in Hong Kong and Singapore. Li SC, Ong SC, Lim SG, Yeoh KG, Kwong KS, Lee V, Lee W, Lau J, Wong I, Kung N, Leung WT, Chan HL, Chan FK, Sung JJ, Lee KK, J Clin Gastroenterol 2004 38 Suppl 136 S143 15602161
7. Household catastrophic health expenditure: a multicountry analysis. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ, Lancet 2003 362 111 117 10.1016/S0140-6736(03)13861-5 12867110 (Pubitemid 36831020)
8. Preventing impoverishment through protection against catastrophic health expenditure. Kawabata K, Xu K, Carrin G, Bull World Health Organ 2002 80 612 12219150
9. Study on the Direct Economic Burden of Hepatitis B and its Economic Impact on Family in Shenzhen City. Liang S, Zhang SX, Qi-shan MA, Chinese Health Economics 2011 30 2 56 58
10. Analysis of economic expense of Chronic Hepatitis B. Chen X, Chen H, Alison TM, Chinese J Hosp Adm 2003 19 1 58 59